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Abstract: Synuclein (α,β, andγ) proteins are highly expressed in presynaptic terminals, and significant
data exist supporting their role in regulating neurotransmitter release. Targeting the gene encoding
α-synuclein is the basis of many animal models of Parkinson’s disease (PD). However, the physiological
role of this family of proteins in not well understood and could be especially relevant as interfering with
accumulation of α-synuclein level has therapeutic potential in limiting PD progression. The long-term
effects of their removal are unknown and given the complex pathophysiology of PD, could exacerbate
other clinical features of the disease, for example dysautonomia. In the present study, we sought to
characterize the autonomic phenotypes of mice lacking all synucleins (α, β, and γ; αβγ−/−) in order to
better understand the role of synuclein-family proteins in autonomic function. We probed respiratory
and cardiovascular reflexes in conscious and anesthetized, young (4 months) and aged (18–20 months)
αβγ−/− male mice. Aged mice displayed impaired respiratory responses to both hypoxia and
hypercapnia when breathing activities were recorded in conscious animals using whole-body
plethysmography. These animals were also found to be hypertensive from conscious blood pressure
recordings, to have reduced pressor baroreflex gain under anesthesia, and showed reduced termination
of both pressor and depressor reflexes. The present data demonstrate the importance of synuclein in
the normal function of respiratory and cardiovascular reflexes during aging.
Keywords: aged mouse; baroreflex; hypoxia; hypercapnia; Parkinson’s disease; synuclein
1. Introduction
Synucleins (α, β, and γ) are a family of highly-conserved vertebrate-specific proteins, specifically
enriched in pre-synaptic terminals of neurons and thought to be involved in regulating vesicular release
and recycling of neurotransmitters [1–3]. The alpha-synuclein (α-syn) member of this family has come
under intense research scrutiny because the pathophysiology of Parkinson’s disease (PD) is particularly
linked with α-syn abnormalities due to the discovery of a rare form of familial PD that was mapped to a
single nucleotide change in the α-syn gene [4]. Subsequently, genome-wide association studies (GWAS)
found α-syn to be the most relevant gene in cases of idiopathic PD. This led to the development of
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numerous animal models of PD based on the mutation or over-expression of α-syn [5]. Additionally,
there is an important role of α-syn in regulation of key stages of dopamine release, reuptake and
recycling [6]. However, despite playing such an important role in pathology, surprisingly little was
known about the physiological role of this protein. This was, in part, due to the sequence homology
of the genes encoding the three members of this protein family [7,8]. The pattern of expression,
predominantly in neuronal tissues, of these three proteins also has significant overlap, and while
some tissues may express more than one member, generally all three are expressed simultaneously [9].
Synucleins seem to operate in redundancy as in single or double syn-knockout mice display decline in
striatal dopamine and impaired synaptic function over time [10–12]. However,αβγ-syn triple-knockout
(αβγ−/−) mice displayed a more severe age-dependent phenotype in comparison to single or double
knockouts [2,7,13,14].
Autonomic deficits in PD are well-known to contribute to the overall pathology [15–17] but
have recently received renewed attention because this dysfunction may precede the onset of motor
symptoms [18–20]. Understanding how autonomic dysfunction associated with PD can be better
treated or used for diagnosis requires studies with animal models. Indeed, both toxin-based animal
models and those that rely on the (over)expression of (human) α-syn have been shown to recapitulate
many of the features of PD dysautonomia [21]. Recently, reducing α-synuclein level has gained
attention as a therapeutic method to limit the progression of PD [12]; however, experimental evidence
on the long-term effects of removing α-synuclein on the development and normal function of the
autonomic nervous system is lacking. Accordingly, in the present study, we sought to characterize the
respiratory and cardiovascular phenotype of αβγ−/− animals in order to better understand the role of
this protein family in homeostatic autonomic cardiorespiratory responses.
2. Methods
2.1. Ethical Approval
All experiments were performed in accordance with the European Commission Directive
86/609/EEC (European Convention for the Protection of Vertebrate Animals used for Experimental and
Other Scientific Purposes), the UK Home Office (Scientific Procedures) Act (1986), and the US National
Institutes of Health Guide for the Care and Use of Laboratory Animals, with project approval from the
respective Institutional Animal Care and Use Committees.
2.2. Generation of Single-, Double- and Triple-Synuclein-Null Mutant Animals
Generation of the αβγ-synuclein triple-knockout (αβγ−/−) mouse line has been described
previously [14]. All animals were on the same C57Bl/6 genetic background. Briefly, lines of single
synuclein knockout animals were backcrossed with C57Bl/6J mice for more than eight generations.
Intercrossing the resultant animals produced double synuclein knockout and finally, αβγ−/− mice.
Wild-type (WT) littermates were used as controls. Young (3–4 months) and aged (18–20 months) male
mice used in this study were housed in a temperature-controlled facility with a normal light–dark
cycle (12 h:12 h, lights on at 7:00 am). Access to food (standard laboratory rodent diet) and water was
provided ad libitum.
2.3. Physiological Experiments in Conscious Mice
2.3.1. Non-Invasive Breathing Measurement
Respiratory parameters were measured in unrestrained conscious mice by whole-body
plethysmography as described previously [22,23]. Briefly, the mouse was placed in a Plexiglas
recording chamber (~200 mL) that was flushed continuously with room air (unless otherwise required
by the protocol) at a rate of 0.3 L min−1. The animals were allowed to acclimatize to the chamber
environment for ~30 min in room air. After baseline ventilation was measured, the O2 concentration in
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the chamber and thus inspired air was reduced to 15% and 10% for 5 min at each O2 level. Similarly, in
separate experiments, hyperoxic (~33% O2) hypercapnia was induced by incrementally increasing
the concentration of CO2 in the chamber respiratory gas mixture to 3%, 6%, and 9%. Each CO2
concentration was maintained for 5 min. Concentrations of CO2 in the chamber were monitored online
using a fast-response O2/CO2 analyzer (Morgan Medical, Hertford, UK). Respiratory rate (ƒR, breaths
per minute) and tidal volume (VT, normalized per kilogram of body weight) were determined by the
pressure changes in the chamber as described before [23,24]. The pressure signal was amplified, filtered,
recorded, and analyzed offline using Spike2 software (Cambridge Electronic Design, Cambridge, UK).
The measurements of these ventilatory variables were obtained during the last 1–2 min of baseline
recordings (i.e., before exposure to the gas mixtures) and during a 2 min period near the termination
of each hypoxia or hypercapnia stimulus when the breathing pattern was stabilized. Hypoxia- or
hypercapnia-induced changes in ƒR, VT, and minute ventilation (VE = ƒR × VT) were analyzed from
the recordings.
2.3.2. Non-Invasive Blood Pressure Measurement
Non-invasive blood pressure measurements were conducted in conscious mice of all strains by
means of an integrated tail-cuff plethysmography system (CODA system, Kent Scientific, Torrington, CT,
USA; [25]). Blood pressure measurements were performed by the same investigator and at the same time
of day for all mice within each experimental group. Mice were moved to a quiet, temperature-controlled
area 12 h before measurements commenced. Air temperature was between 32 and 34 ◦C, thermoneutral
for rodents, in order to ameliorate increases in sympathetic drive associated with cold stress [26].
Animals were restrained in a tube with nose-cone attachment (Kent Scientific) and placed on a heated
platform at 37 ◦C. The tail was instrumented with a cuff and volume-pressure recording sensor. At least
ten consecutive volume–pressure measurements were taken over a period of 15 min and averaged to
determine resting arterial blood pressure and heart rate. Measurements were repeated the following
day and all variables reported are an average of two consecutive measurement periods.
2.4. Anesthetized Preparation for Baroreflex Measurements
2.4.1. Surgical Preparation
Mice were anesthetized with urethane (ethyl carbamate; 1.2 g kg−1, i.p.) and both the left common
carotid artery and right jugular vein were cannulated using fine-bore polyethylene tubing (ID.38 OD
1.09 mm; Smith’s Medical, Kent, UK) filled with heparinized saline. Mice were allowed to freely breath
room air and placed on a homeothermic heating pad to maintain body temperature at 37 ± 5 ◦C. The
arterial cannula was connected to a pressure transducer for measurement of blood pressure. Depth of
anesthesia was assessed by absence of withdrawal from paw-pinch and the stability of blood pressure
and heart rate recorded. Additionally, two subcutaneous electrodes were placed on left and right flanks
for recording of ECG. Signals were amplified and filtered (High-pass 50 Hz, low-pass 20 kHz) using
a Neurolog System (Digitimer, Wellyn Garden City, UK). Recordings of the physiological variables
obtained in anesthetized animals were digitized using a Cambridge Electronic Design (CED) power1401
interface and analyzed using Spike2 software.
2.4.2. Baroreflex Protocol
After allowing the animal to stabilize approximately 10 min following surgery, the baroreflex
protocol was started. Animals were subjected to three randomized doses of phenylephrine (5, 10 and
25 µg per animal) and/or sodium nitroprusside (5, 15 and 30 µg per animal). Drugs were administered
slowly over 5–10 s via the jugular vein cannula in volumes that did not exceed 50 µL. Maximum
changes in mean arterial blood pressure and R-R interval were calculated from the blood pressure
and ECG trace, respectively. Baroreflex gain was calculated by the change in heart rate divided by the
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change in blood pressure. Additionally, the ‘overshoot’ in heart rate and systolic blood pressure after
returning to baseline following activation of the pressor reflex and depressor reflexes was assessed.
2.4.3. Morphometries
At the end of the experiment, animals were humanely sacrificed with an overdose of pentobarbital
sodium (30 mg kg−1). The heart was rapidly removed and rinsed with saline. Total heart weight
was measured and then the left ventricle was carefully dissected free of the remaining tissue under
microscopic guidance and weighed.
2.5. Data Analysis
Data are reported as mean ± SEM and plotted as individual points using Prism 8 (GraphPad Inc.,
San Diego, CA, USA). Datasets were tested for normality using a Shapiro–Wilk normality test and were
compared by Kruskal–Wallis ANOVA by ranks, Mann–Whitney U rank test, or Wilcoxon matched-pairs
signed-rank test as appropriate. Differences between groups with p < 0.05 were considered significant.
3. Results
3.1. Respiratory Activity in Conscious Mice
3.1.1. Resting Breathing in Room Air and Hyperoxic Condition
The resting breathing frequency (ƒR) of youngαβγ−/− mice in room air (i.e., normoxia/normocapnia)
was higher when compared to the wild-type mice (241 ± 17 min−1 (n = 8) vs. 166 ± 11 min−1 (n = 7);
p = 0.014, Mann–Whitney U rank test; Figure 1A). Similarly, with αβγ−/− aged mice, ƒR remained
higher (259 ± 15 min−1 (n = 10) vs. 195 ± 13 min−1 (n = 9) than age-matched wild-type mice; p = 0.010;
Figure 1B). However, in the hyperoxia/normocapnia condition (~33% O2 in the inspired air), ƒR was
not different in younger mice (245 ± 6 min−1 (n = 8) vs. 251 ± 8 min−1 (n = 7); p = 0.44, Mann–Whitney
U rank test; Figure 1A), but in this condition, ƒR remained higher (by 24%) in aged αβγ−/− mice
(268 ± 13 min−1 (n = 10) vs. 204 ± 15 min−1 (n = 9); p = 0.001, Mann–Whitney U rank test; Figure 1B).
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Figure 1. αβγ−/− mice display age-dependent increases in resting breathing frequency in normoxia
and hyperoxia. (A,B) Population data from whole-body plethysmography measurements showing
respiratory rate (ƒR) in young (A) and aged (B) WT and αβγ−/− mice at room air (21% O2) and hyperoxic
conditions (33% O2). p—Mann–Whitney U rank test.
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3.1.2. Ventilatory Response to Hypoxia
ƒR, VT, and VE responses during mild hypoxic challenges (15% O2 in the inspired air) were not
different in young or aged transgenic mice when compared to their wild-type counterparts (data not
shown). However, when challenged with moderate hypoxia (10% O2 in the inspired air), ƒR increased
in young wild-type mice by ~41% (234 ± 10 min−1 vs. 166 ± 11 min−1 in room air, n = 7; p = 0.016,
Wilcoxon matched-pairs signed-rank test; Figure 2A). In contrast, during hypoxia, ƒR decreased in
young αβγ−/− animals (by ~8%, 222 ± 17 min−1 vs. 241 ± 16 min−1 in room air, n = 8; p = 0.047,
Wilcoxon matched-pairs signed-rank test; Figure 2A). Despite this decrease in ƒR, the hypoxia-induced
ƒR in young αβγ−/− animals was not different from wild-type (p = 0.7, Mann–Whitney U rank test;
Figure 2B). Hypoxic challenge increased tidal volume (VT) by ~37% in wild-type (2.5 ± 0.2 a.u. vs.
1.8 ± 0.1 a.u. in normoxia; p = 0.016, Wilcoxon matched-pairs signed-rank test) and by ~20% in
αβγ−/− animals (2.4 ± 0.2 a.u. vs. 1.8 ± 0.1 a.u. at normoxia, p = 0.039, Wilcoxon matched-pairs
signed-rank test; Figure 2B). However, the magnitude of the hypoxic VT was not different between
groups. In addition, hypoxia-induced minute ventilation (VE) was quantitatively similar between
young wild-type and αβγ−/− mice (525 ± 42 a.u. vs. 578 ± 73 a.u. in wild-type; p = 0.5, Mann–Whitney
U rank test; Figure 2B).
In aged αβγ−/− animals, hypoxia did not affect ƒR (259 ± 15 min−1 vs. 260 ± 12 min−1 in room air,
n = 10; p = 0.77, Wilcoxon matched-pairs signed-rank; Figure 2C). Although hypoxia increased ƒR in
aged wild-type mice by ~37% (271 ± 12 min−1 vs. 195 ± 13 min−1 in room air, n = 9; p = 0.004, Wilcoxon
matched-pairs signed-rank; Figure 2C), the hypoxic breathing rate was not different between aged
αβγ−/− and wild-type mice (260 ± 12 min−1 vs. 271 ± 12 min−1 in wild-type; p = 0.55, Mann–Whitney
U rank test; Figure 2D). During hypoxia VT was also increased in aged wild-type mice by ~19%
(2.2 ± 0.1 a.u. vs. 1.9 ± 0.1 a.u. at normoxia, n = 10; p = 0.037, Wilcoxon matched-pairs signed-rank test).
However, hypoxia did not cause a significant increase in VT in aged αβγ−/− animals (1.97 ± 0.1 a.u.
vs. 1.91 ± 0.1 a.u. at normoxia, n = 12; p = 0.52, Wilcoxon matched-pairs signed-rank test; Figure 2B).
As opposed to younger mice, hypoxia-induced VE was decreased in aged αβγ−/− animals (513 ± 44 a.u.
vs. 651 ± 31 a.u. in wild-type; p = 0.016, Mann–Whitney U rank test; Figure 2B).
3.1.3. Ventilatory Response to Hypercapnia
ƒR, VT, and VE responses during mild hypercapnic challenges (3% CO2 in the inspired air)
were not different in young or aged transgenic mice when compared to their wild-type counterparts
(data not shown). Similarly, there were no differences in respiratory responses to moderate hypercapnia
challenge (6% CO2 in the inspired air) and severe hypercapnia challenge (9% CO2 in the inspired air)
between young αβγ−/− and wild-type mice (Figure 3A,B). However, compared to aged-wild-type mice,
aged αβγ−/− mice displayed impaired CO2-induced augmentation of ƒR in 6% CO2 (291 ± 7 min−1 vs.
268 ± 13 min−1 in normocapnia, n = 10; p = 0.08, Wilcoxon matched-pairs signed-rank test) and 9%
CO2 (313 ± 11 min−1 vs. 268 ± 13 min−1 in normocapnia, n = 10; p = 0.004, Wilcoxon matched-pairs
signed-rank test; Figure 3C). In addition, CO2-induced ƒR in aged αβγ−/− mice was found to be lower
by 12% [291 ± 7 min−1 (n = 10) vs. 332 ± 13 min−1 in wild-type (n = 9); p = 0.023, Mann–Whitney U rank
test] and 20% [313 ± 11 min−1 (n = 10) vs. 398 ± 8 min−1 in wild-type (n = 9); p < 0.001, Mann–Whitney
U rank test], respectively (Figure 3D).
In addition, the CO2-induced increase in VE was lower in aged αβγ−/− mice when challenged
with 6 and 9% CO2 by 23% (834 ± 62 a.u. vs. 1077 ± 97 a.u. in wild-type; p = 0.07, Mann–Whitney U
rank test) and 28% (1414 ± 63 a.u. vs. 1974 ± 105 a.u. in wild-type; p = 0.001, Mann–Whitney U rank
test; Figure 3D), respectively.
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3.2. Heart Morphometry Parameters
Heart morphometry measurements were taken from both aged and young αβγ−/− mice.
Body, heart and left ventricle weights were recorded and heart to body weight ratio was calculated.
No significant differences (p > 0.05, Mann–Whitney U rank test) between phenotypes in either age
groups were detected (Table 1).
Table 1. Comparison of morphometric parameters between αβγ−/− and wild-type control animals for
both young and aged groups. Means ± S.E.M were compared with Mann–Whitney U rank test.
Young
Wild Type
Young
αβγ−/− p Value
Aged
Wild Type
Aged
αβγ−/− p Value
n 6 6 6 6
Body
Weight (g) 26.8 ± 0.5 28.2 ± 0.6 0.13 27.2 ± 0.7 25.6 ± 0.8 0.08
Heart
Weight (g) 0.156 ± 0.005 0.157 ± 0.006 0.85 0.183 ± 0.2 0.157 ± 0.01 0.18
LV
Weight (g) 0.088 ± 0.006 0.091 ± 0.002 0.79 0.113 ± 0.1 0.092 ± 0.005 0.14
HW/BW
Ratio 5.78 ± 0.04 5.59 ± 0.20 0.23 6.71 ± 0.5 6.39 ± 0.4 0.53
3.3. Hemodynamics in Conscious Mice
In young animals, no differences in blood pressure or heart rate were detected between genotypes
in any variable measured (p > 0.05, Mann–Whitney U rank test; Table 2). However, resting systolic,
diastolic and MAP were all significantly (p = 0.015, Mann–Whitney U rank test) higher in aged αβγ−/−
compared to wild-type animals (Table 2), though basal heart rate was not different between genotypes
in aged mice. Furthermore, we found no significant difference in hemodynamic measurements between
single synuclein-null (α−/−, β−/−, γ−/−) and the double synuclein-null (αγ−/−) animals when compared
to the aged control group (Table 3).
Table 2. Hemodynamic parameters measured using tail-cuff plethysmograph in conscious αβγ−/−
and wild-type control animals for both young and aged groups. Means ± S.E.M were compared with
Mann–Whitney U rank test.
Young
Wild Type
Young
αβγ−/− p Value
Aged
Wild Type
Aged
αβγ−/− p Value
n 8 9 8 8
Diastolic BP
(mmHg) 86.7 ± 4.2 87.8 ± 3.4 0.94 121 ± 5.9 147 ± 6.9 0.02
Systolic BP
(mmHg) 121.9 ± 5.1 125.0 ± 3.6 0.72 161 ± 7.0 185 ± 7.0 0.02
Mean BP
(mmHg) 98.1 ± 4.4 99.8 ± 3.4 0.87 133.9 ± 6.2 159.5 ± 6.9 0.02
Heart rate
(bpm) 568 ± 33 572.0 ±1 9 0.73 599 ± 37 632 ± 9 0.92
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Table 3. Hemodynamic parameters measured using tail-cuff plethysmograph in conscious aged single
synuclein-null (α−/−, β−/−, γ−/−) and the double synuclein-null (αγ−/−) animals. Means ± S.E.M were
compared with Mann–Whitney U rank test.
Aged
Wild Type
Aged
α−/− p Value
Aged
β−/− p Value
Aged
γ−/− p Value
Aged
αγ−/− p Value
n 8 3 5 3 3
Diastolic BP
(mmHg) 119 ± 7 130 ± 6 0.38 137 ± 6 0.093 118 ± 8 0.667 120 ± 5 0.67
Systolic BP
(mmHg) 159 ± 6 163 ± 5 0.92 171 ± 6 0.617 152 ± 7 0.170 155 ± 6 0.17
Mean BP
(mmHg) 132 ± 6 141 ± 5 0.63 148 ± 6 0.127 129 ± 8 0.667 131 ± 5 0.55
Heart rate
(bpm) 572 ± 45 636 ± 38 >0.99 651 ± 11 0.343 625 ± 49 0.667 601 ± 19 0.33
Interestingly, we found both aged wild-type and the TKO mice were significantly hypertensive
compared to their young counterparts. Resting systolic, diastolic and MAP, but not heart rate, were all
significantly (p < 0.001, Mann–Whitney U rank test) higher in the aged vs. the young wild-type mice.
3.4. Hemodynamics under Anesthesia
Systolic, diastolic, mean arterial pressure and heart rate were measured over a 5-min period
immediately prior to commencement of the baroreflex protocol. Under anesthesia, there was no
significant difference detected in any parameter between genotypes (p < 0.05; Mann–Whitney U rank
test; Table 4).
Table 4. Hemodynamic parameters measured under urethane anesthesia (1.2 g kg−1, i.v.) in αβγ−/−
and wild-type control animals for both young and aged groups. Means ± S.E.M were compared with
Mann–Whitney U rank test.
Young
Wild Type
Young
αβγ−/− p Value
Aged
Wild Type
Aged
αβγ−/− p Value
n 5 5 8 8
Diastolic BP
(mmHg) 78 ± 4 80 ± 5 0.67 72 ± 3 79 ± 4 0.71
Systolic BP
(mmHg) 107 ± 3 109 ± 5 0.74 96 ± 4.0 94 ± 5 0.77
Mean BP
(mmHg) 65 ± 5 67 ± 5 0.65 83 ± 4 85 ± 4 0.92
Heart rate
(bpm) 658 ± 7 623 ± 22 0.22 575 ± 33 626 ± 25 0.36
3.5. Baroreflex
3.5.1. Baroreflex Sensitivity
Baroreflex sensitivity was assessed over a range of blood pressure changes from −30 to +50 mmHg
(Figure 4). No significant differences in either the pressor or the depressor reflex were detected in the
young animals between genotypes (Figure 4A,B). In aged animals, the pressor reflex was found to
be significantly attenuated in αβγ−/− subjects (1.1 ± 0.2 (n = 12) vs. 0.6 ± 0.1 bpm mmHg−1 (n = 8)
compared to aged wild-type mice; Figure 4C, p = 0.02, Mann–Whitney U rank test). However, there
was no difference found (p = 0.84; Mann–Whitney U rank test) in depressor reflex gain between aged
αβγ−/− and aged wild-type animals (−5.3 ± 0.3 (n = 6) vs. −5.3 ± 0.3 bpm mmHg−1 (n = 6, Figure 4D)).
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3.5.2. Baroreflex Recovery
In order to gain a more complete understanding of how αβγ-synuclein deletion affects baroreflex,
the recovery period after baroreflex activation was also analyzed. Following activation of the depressor
reflex, restoration of heart rate was assessed in terms of a maximum change from baseline. Similarly,
following activation of pressor reflex, restoration of diastolic blood pressure was assessed in terms of a
maximum change from baseline. Decreases in heart rate and decreases in blood pressure following
activation of the depressor and pressor reflex, respectively, were matched across genotypes and
the maximum change above baseline was calculated (Figure 5A,B). The αβγ−/− mice displayed a
significantly higher overshoot from baseline during heart rate restoration (57 ± 7 (n = 5) vs. 10 ± 3 bpm
(n = 5) in wild-type mice; Figure 5C, p = 0.008, Mann–Whitney U rank test). TKO animals also displayed
a significantly higher overshoot from baseline during systolic blood pressure recovery [6 ± 1 (n = 4)
vs. 12 ± 1 mmHg (n = 4) in wild-type; Figure 5D, p = 0.02, Mann–Whitney U rank test]. Again, no
differences were detected between genotypes in the young animals.
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4. Discussion
In the mammalian nervous system, the presence of other members of the synuclein proteins
(i.e., β- and γ-synuclein) often makes physiological studies of functional roles of α-synuclein difficult.
Therefore, synuclein triple-knockout (αβγ−/−) mice, by removing potential compensatory effects
of β-syn and γ-syn, offers a good model to investigate the physiological function of α-syn in a
synuclein-null, and an age-dependent setting [13]. Data from our study demonstrate that aged mice
lacking αβγ-synuclein proteins have impaired respiratory responses to hypoxia and hypercapnia,
elevated blood pressure, pressor reflex failure, and reduced ability to terminate both pressor and
depressor reflex leading to overcompensation. Young αβγ−/− mice showed compromised respiratory
responses to hypoxic but not hypercapnic challenges. Mutations in α-syn are linked to Parkinson’s
disease [4,27–29], and αβγ−/− mice have been used as a model to study age-dependent phenotypes in
Parkinson’s disease [4,13,30–33]. Moreover, recent data have linked impaired synuclein proteins to the
mitochondrial dysfunction in Parkinson’s disease [34–37].
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4.1. Respiratory Function
Recently, we have shown that during hypoxic challenge, mitochondrial ∆Ψm in brainstem
astrocytes decreases in which this depolarization of the ∆Ψm leads to release of ROS and eventually,
increases in ƒR [38]. Interestingly, in αβγ−/− mice, hypoxia failed to increase ƒR from baseline levels in
both young and aged mice (Figure 2), which suggests that the brainstem of these mice is hypoxic and/or
the central mechanism for low-O2 sensing in these mice are impaired/activated [39]. Previously, we have
shown that astrocytes in the ventrolateral medulla (VLM) by modulating activities of the respiratory
rhythm-generating circuits of the preBötzinger complex [40,41] regulate the ventilatory response to
hypoxia in an ATP-dependent manner [24,38,42]. We also showed that astroglial mitochondria can act
as a central oxygen sensor [24,38]. Abnormal mitochondrial function was reported in αβγ−/− mice, in
which the mitochondrial membrane potential (∆Ψm) was found to be decreased (i.e., depolarized) in
both astrocytes and neurons [43,44]. The fact that hyperoxia (33% O2 in the inspired air) decreased ƒR
in younger αβγ−/− mice but not the aged counterparts further strengthens this hypothesis.
As opposed to impaired age-independent respiratory responses to hypoxia, αβγ−/− mice showed
an age-dependent respiratory response to hypercapnia (6% and 9% CO2 in the inspired air). Our results
are in agreement with age-dependent data reported from 6-hydroxydopamine (6-OHDA)-model of
Parkinson’s disease [45–48] in which injection of 6-OHDA into the striatum/substantia nigra induced
Parkinson’s disease in rats [45] and mice [49], and these rats also exhibited an age-dependent impaired
response to hypercapnic challenges. However, 6-OHDA rats showed normal augmentation of breathing
when challenged with hypoxia [45]. The fact that respiratory responses to hypoxic challenge were
normal in 6-OHDA rats but were impaired in αβγ−/− mice (this study) can be explained by the fact
that in the 6-OHDA model, the defect is only induced in neurons [45], but both neurons and astrocytes
showed impaired mitochondrial function in the αβγ−/− mice [43].
4.2. Cardiovascular Function
Conscious measurements of blood pressure show a clear age-dependent increase in mean arterial
pressure in animals lacking all three synuclein sub-types (Table 2). The baroreflex (pressor reflex)
was also found to be inhibited in aged animals, as well as an increased overshoot of both heart rate
and blood pressure during the recovery phase of the pressor and depressor reflexes, respectively.
We did not detect any differences in heart morphometry (Table 1) between the mouse strains that could
compound any differences seen in cardiovascular physiology. This was in agreement with the other
report of this strain of mice being phenotypically normal compared with wild types in size, weight and
gross brain anatomy, up to 14 months of age [14]. Therefore, we suggest that the data indicates the
features of the cardiovascular phenotype are neurogenic in origin.
Together, the cardiovascular phenotype suggests deletion of αβγ-synuclein produces a chronic
reduction of parasympathetic (vagal) tone and inability to appropriately regulate sympathetic tone as
previously indicated by altered cardiac parasympathetic control [50]. The impaired parasympathetic
tone can explain the exacerbation of the age-related hypertension as seen in the aged wild-type
animals (compared to the young wild-type) in the present study and reported previously [51].
Parasympathetic tone has been shown to be an important determinant of blood pressure in a
model of hypertension, where chronic augmentation of parasympathetic tone has been shown to be
anti-hypertensive [52]. Aging of the autonomic nervous system can be characterized as a generalized
shifting of the sympathetic-parasympathetic balance [53] leading to various cardiovascular pathologies,
including hypertension [54]. Deletion of αβγ-synuclein produces impairment of circuits controlling the
autonomic nervous system that parallels the age-related synaptic dysfunction in the striatum [13,14]
and as a result, exacerbates the shift from parasympathetic to the preponderance of sympathetic tone.
This is supported by the autonomic symptoms occurring before or in parallel with the movement and
cognitive symptoms of the synucleinopathies [55].
This pattern of autonomic dysfunction is also supported by the impaired baroreflex displayed
by aged αβγ−/− mice. Baroreflex activation maintains blood pressure and heart rate within narrow
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physiological ranges through activation or withdrawal of central sympathetic and parasympathetic
outflow in response to input from baroreceptors; decreases in blood pressure result in sympathetic
activation and parasympathetic withdrawal, and blood pressure increases result in the opposite response.
The impaired pressor reflex suggests a similar dysfunction in sympathetic circuits or peripheral
sympathetic signaling as sympathetic outflow must be engaged in order to restore blood pressure
after it is lowered, as previously suggested [56]. Similarly, the failure of blood pressure and heart
rate restoration following activation of either the pressor or depressor reflex further indicates a lack
of appropriate autonomic control. This could be due to the lack of parasympathetic tone allowing
sympathetic activation to dominate during baroreflex activation. This would cause an overshoot of
heart rate by hyperactivation of cardiac beta-adrenoceptors when recovering from depressor reflex
activation and similar inappropriate activation of vascular alpha-adrenoceptors. A similar pattern
of baroreflex dysregulation was reported in mice that express a mutant form of α-synuclein [53],
again suggesting that autonomic circuits are susceptible to the same pathology as seen in the striatum.
Interestingly, there was no differences in blood pressure detected in animals lacking a single
synuclein or in the double (αγ) knockout animals (Table 3). This suggests that there is a significant
compensation between the three members of synuclein family as all three must be absent for increased
blood pressure to be observed. This is in concordance with data of synaptic dysfunction in the
striatum [14].
5. Summary and Conclusions
The present data support a role of synuclein in the normal function of the autonomic nervous
system and central respiratory control during aging. Previous data have been collected using
toxin-based models of or overexpression of mutant α-synuclein proteins and have shown autonomic
and respiratory deficits. However, until now, nothing has been known about the role of α-synuclein in
normal autonomic physiology. We have shown αβγ−/− mice have marked age-related respiratory and
cardiovascular deficits. Our data suggest synuclein proteins are necessary for healthy aging in central
respiratory and autonomic neuronal circuits and any treatment that reduces the availability of synuclein
proteins over time may decrease the cardio-respiratory reflexes and worsen the treatment outcomes.
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